The Leadership Team at Impel Pharmaceuticals is responsible for guiding the company's strategic direction and overseeing operational efficiency in the development and commercialization of innovative CNS therapies. This team collaborates across market access, quality assurance, and commercial operations to ensure that the novel POD™ delivery platform effectively meets regulatory standards and market needs, ultimately aiming to enhance patient outcomes and expand access to life-changing treatments.
View all